Press Release Forum [] Forum Index

Press Release Forum []
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!


Cytokines and Inflammation conference

Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases
View previous topic :: View next topic  
Author Message

Joined: 03 May 2007
Posts: 20

PostPosted: Wed Dec 19, 2007 8:50 pm    Post subject: Cytokines and Inflammation conference Reply with quote

MONROVIA, CA –Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL.

Dr. Oppenheim has done many pioneering studies of cytokines including IL-1 and participated in the patented discoveries of interleukin-8 and MCP-1. His discovery of cytokines has given him the nickname “Father of Cytokines”. Dr. Oppenheim has published well over 550 papers (includes books, chapters, reprints and reviews) during his impressive career. Dr. Joost J. Oppenheim along Dr. Scott Durum instigated the founding of the International Cytokine Society in 1993

The topic Dr. Oppenheim will be presenting on is Regulation of T Regulatory Cells. Dr. Oppenheim is currently studying the structure-function relationships of chemoattractant cytokines. His studies are focused on the effects of chemokines and downstream effector molecules such as defensins and cathelicidin LL-37 on innate and adaptive immunity, the regulation of angiogenesis by chemokines, and identification of chemokine inhibitors present in medicinal plant extracts and herbal preparation.

Dr. Oppenheim has also been investigating the “cross-talk” resulting in phosphorylation and mutual inactivation of chemokine and opioid receptors. This results in bidirectional desensitization of the receptors and provides a mechanism by which opioids can suppress the activities of proinflammatory chemokines. Conversely, chemokines can suppress opioid receptor functions thus presumably contributing to the increased perception of pain associated with inflammation.

The conference will also feature presentations from Alba Therapeutics, Amgen, AstraZeneca, Biogen-Idec, ChemoCentryx, Children's Hospital of Pittsburgh, Cleveland Clinic, FDA CDER, Genentech, Genomics Institute of the Novartis Research Foundation, Hôpital Edouard Herriot, McGill University, MedImmune, Merck, Merck-Serono, NIH, Novo Nordisk, Pfizer, Roche Palo Alto, Schering Plough, St. Judes Children’s Research Hospital, University of Glasgow, University Medical Center Utrecht, and University of Massachusetts Medical School. The full agenda is available online at


GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
Back to top
View user's profile Send private message Send e-mail
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases All times are GMT - 4 Hours
Page 1 of 1

Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release


Editor's pick: